Metered Dose Inhaler Vaporizing Cannabis Plant Material
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The use of cannabis as a pharmaceutical is limited due to difficulties in accurate and precise dosing, leading to challenges in its administration and regulation, particularly in pulmonary delivery methods, which lack standardization and consistency, hindering its acceptance as a mainstream medical treatment.
Innovation Solution
A metered dose inhaler device configured to vaporize predetermined amounts of cannabinoids from cannabis, allowing for controlled and reproducible pulmonary delivery, with a controller to adjust doses based on pharmacokinetic and pharmacodynamic effects, ensuring precise therapeutic effects and minimizing adverse effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If cannabis is administered through traditional pulmonary delivery methods (smoking), then rapid absorption and efficient cannabinoid delivery is achieved, but variable bioavailability and harmful pyrolytic byproducts are generated
Solution Approach 1:
The patent changes the temperature parameter from combustion range (above 230-235°C) to vaporization range (170-190°C), transforming the harmful pyrolytic process into a beneficial vaporization process that delivers cannabinoids rapidly without generating toxic byproducts
Solution Approach 2:
The patent converts the harmful effect of heat (which causes pyrolysis and toxic byproducts) into a beneficial vaporization process by precisely controlling temperature to remain below the combustion point, thus eliminating harmful factors while maintaining rapid absorption
2Object-affected harmful factors
If cannabis is administered through oral edibles, then avoidance of respiratory hazards is achieved, but slow and erratic absorption leads to delayed onset and unsatisfactory analgesia
Solution Approach 1:
The patent introduces the lung as an intermediary absorption site with its large surface area and rich blood supply, enabling rapid absorption without respiratory hazards by using controlled vaporization rather than combustion, thus bridging the gap between oral safety and inhalation speed
3Speed
If cannabis is administered through smoking, then rapid cannabinoid delivery is achieved, but heterogeneous bioavailability and inconsistent dosing occur
Solution Approach 1:
The patent segments the cannabis plant material into small uniform particles and delivers them through controlled puffs, with each puff providing a consistent, measurable dose through the vaporization device, thereby achieving both rapid delivery and precise dosing control
4Adaptability or versatility
If cannabis is used as a natural substance, then a wide range of therapeutic effects is available, but difficulties in quantifying active agents prevent controlled administration
Solution Approach 1:
The patent performs preliminary action by pre-weighing and pre-dosing the cannabis plant material into standardized cartridges or chambers before use, ensuring that each administration delivers a known, controlled amount of active agents while maintaining the versatility of natural cannabis therapy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system enables accurate and consistent delivery of cannabis-derived cannabinoids, bridging the gap between natural substances and pharmaceutical standards, allowing for standardized medical use by achieving desired therapeutic effects while minimizing adverse effects.
Implementation Method 1
a heating element adapted to apply heat to a portion of the plant material matter to thereby vaporize one or more pharmaceutically active agents
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
Provided herein is a system that includes a metered dose inhaler device for pulmonary delivering to a subject at least one pre-determined vaporized amount of at least one pharmacologically active agent being in a plant material, wherein vaporization is effected by controllably heating the plant material so as to vaporize a pre-determined vaporized amount of the agent; the system further includes a controller in communication with the inhaler device, configured to control the pre-determined vaporized amount based on data indicative of at least one pharmacodynamic effect induced by the agent in the subject.